Curcumin inhibits the formation of capillary-like tubes by rat lymphatic endothelial cells

Cancer Letters

Volumn 251, Issue 2, 2007, Pages 288-295

  Matsuo, Mitsuhiro ^a   Sakurai, Hiroaki ^a   Koizumi, Keiichi ^a   Saiki, Ikuo ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Akt; Berberine; Curcumin; Lymphangiogenesis; Lymphatic metastasis; MMP 2

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 4 (3 BROMOANILINO) 6,7 DIMETHOXYQUINAZOLINE; BERBERINE; CURCUMIN; EPIDERMAL GROWTH FACTOR RECEPTOR; GEFITINIB; GELATINASE A; I KAPPA B KINASE; ILOMASTAT; MATRIGEL; PHOSPHATIDYLINOSITOL 3 KINASE; VIRUS T ANTIGEN;

ANIMAL CELL; ARTICLE; CAPILLARY WALL; CELL ADHESION; CELL IMMORTALIZATION; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG INHIBITION; IN VITRO STUDY; LYMPH VESSEL ENDOTHELIUM; LYMPHANGIOGENESIS; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIMIAN VIRUS 40; THORACIC DUCT; WESTERN BLOTTING;

ANIMALS; BERBERINE; CAPILLARIES; CELL ADHESION; CELL LINE, TUMOR; CELL SURVIVAL; CURCUMIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; I-KAPPA B KINASE; MATRIX METALLOPROTEINASE 2; NEOPLASM METASTASIS; PROTO-ONCOGENE PROTEINS C-AKT; RATS;

RATTUS;

EID: 34247591871     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2006.11.027     Document Type: Article

References (37)

1. Maheshwari R.K., Singh A.K., Gaddipati J., and Srimal R.C. Multiple biological activities of curcumin: a short review. Life Sci. 78 (2006) 2081-2087
2. Sharma R.A., Gescher A.J., and Steward W.P. Curcumin: the story so far. Eur. J. Cancer 41 (2005) 1955-1968
3. Ohashi Y., Tsuchiya Y., Koizumi K., Sakurai H., and Saiki I. Prevention of intrahepatic metastasis by curcumin in an orthotopic implantation model. Oncology 65 (2003) 250-258
4. Amin A.H., Subbahaiah T.V., and Abbasi K.M. Berberine sulfate: antimicrobial activity, bioassay, and mode of action. Can. J. Microbiol. 15 (1969) 1067-1076
5. Kuo C.L., Chi C.W., and Liu T.Y. The anti-inflammatory potential of berberine in vitro and in vivo. Cancer Lett. 2 (2004) 127-137
6. Lin S., Tsai S.C., Lee C.C., Wang B.W., Liou J.Y., and Shyu K.G. Berberine inhibits HIF-1alpha expression via enhanced proteolysis. Mol. Pharmacol. 66 (2004) 612-619
7. Ichiki K., Mitani N., Doki Y., Hara H., Misaki T., and Saiki I. Regulation of activator protein-1 activity in the mediastinal lymph node metastasis of lung cancer. Clin. Exp. Metastasis 18 (2000) 539-545
8. Mitani N., Murakami K., Yamaura T., Ikeda T., and Saiki I. Inhibitory effect of berberine on the mediastinal lymph node metastasis produced by orthotopic implantation of Lewis lung carcinoma. Cancer Lett. 165 (2001) 35-42
9. Pepper M.S. Lymphangiogenesis and tumor metastasis: myth or reality?. Clin. Cancer Res. 7 (2001) 462-468
10. Saharinen P., Tammela T., Karkkainen M.J., and Alitalo K. Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation. Trends Immunol. 25 (2004) 387-395
11. Stacker S.A., Achen M.G., Jussila L., Baldwin M.E., and Alitalo K. Lymphangiogenesis and cancer metastasis. Nat. Rev. Cancer 2 (2002) 573-583
12. Matsuo M., Koizumi K., Yamada S., Tomi M., Takahashi R.-I., Ueda M., Terasaki T., Obinata M., Hosoya K.-I., Ohtani O., and Saiki I. Establishment and characterization of conditionally immortalized endothelial cell lines from the thoracic duct and inferior vena cava of tsA58/EGFP double-transgenic rats. Cell Tissue Res. 326 (2006) 749-758
13. Glesne D.A., Zhang W., Mandava S., Ursos L., Buell M.E., Makowski L., and Rodi D.J. Subtractive transcriptomics: establishing polarity drives in vitro human endothelial morphogenesis. Cancer Res. 66 (2006) 4030-4040
14. Singh S., and Aggarwal B.B. Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane). J. Biol. Chem. 270 (1995) 24995-25000
15. Tomita M., Matsuda T., Kawakami H., Uchihara J.N., Okudaira T., Masuda M., Ohshiro K., and Mori N. Curcumin targets Akt cell survival signaling pathway in HTLV-I-infected T-cell lines. Cancer Sci. 97 (2006) 322-327
16. Hussain A.R., Al-Rasheed M., Manogaran P.S., Al-Hussein K.A., Platanias L.C., Al Kuraya K., and Uddin S. Curcumin induces apoptosis via inhibition of PI3'-kinase/AKT pathway in acute T cell leukemias. Apoptosis 11 (2006) 245-254
17. Squires M.S., Hudson E.A., Howells L., Sale S., Houghton C.E., Jones J.L., Fox L.H., Dickens M., Prigent S.A., and Manson M.M. Relevance of mitogen activated protein kinase (MAPK) and phosphotidylinositol-3-kinase/protein kinase B (PI3K/PKB) pathways to induction of apoptosis by curcumin in breast cells. Biochem. Pharmacol. 65 (2003) 361-376
18. Kalmes A., Daum G., and Clowes A.W. EGFR transactivation in the regulation of SMC function. Ann. N. Y. Acad. Sci. 947 (2001) 42-54
19. Matsuo M., Sakurai H., Ueno Y., Ohtani O., and Saiki I. Activation of MEK/ERK and PI3K/Akt pathways by fibronectin requires integrin alphav-mediated ADAM activity in hepatocellular carcinoma: a novel functional target for gefitinib. Cancer Sci. 97 (2006) 155-162
20. Nguyen M., Arkell J., and Jackson C.J. Human endothelial gelatinases and angiogenesis. Int. J. Biochem. Cell Biol. 33 (2001) 960-970
21. Ma F.X., and Han Z.C. Akt signaling and its role in postnatal neovascularization. Histol. Histopathol. 20 (2005) 275-281
22. Shiojima I., and Walsh K. Role of Akt signaling in vascular homeostasis and angiogenesis. Circ. Res. 90 (2002) 1243-1250
23. Chen J., Somanath P.R., Razorenova O., Chen W.S., Hay N., Bornstein P., and Byzova T.V. Akt1 regulates pathological angiogenesis, vascular maturation and permeability in vivo. Nat. Med. 11 (2005) 1188-1196
24. Ackah E., Yu J., Zoellner S., Iwakiri Y., Skurk C., Shibata R., Ouchi N., Easton R.M., Galasso G., Birnbaum M.J., Walsh K., and Sessa W.C. Akt1/protein kinase Balpha is critical for ischemic and VEGF-mediated angiogenesis. J. Clin. Invest. 115 (2005) 2119-2127
25. Rutkowski J.M., Boardman K.C., and Swartz M.A. Characterization of lymphangiogenesis in a model of adult skin regeneration. Am. J. Physiol. Heart Circ. Physiol. 291 (2006) H1402-H1410
26. Ueda M., Hung Y.C., Terai Y., Kanda K., Kanemura M., Futakuchi H., Yamaguchi H., Akise D., Yasuda M., and Ueki M. Vascular endothelial growth factor-C expression and invasive phenotype in ovarian carcinomas. Clin. Cancer Res. 11 (2005) 3225-3232
27. Wu Z.Y., Li J.H., Zhan W.H., and He Y.L. Lymph node micrometastasis and its correlation with MMP-2 expression in gastric carcinoma. World J. Gastroenterol. 12 (2006) 2941-2944
28. Patel B.P., Shah P.M., Rawal U.M., Desai A.A., Shah S.V., Rawal R.M., and Patel P.S. Activation of MMP-2 and MMP-9 in patients with oral squamous cell carcinoma. J. Surg. Oncol. 90 (2005) 81-88
29. Langenskiold M., Holmdahl L., Falk P., and Ivarsson M.L. Increased plasma MMP-2 protein expression in lymph node-positive patients with colorectal cancer. Int. J. Colorectal Dis. 20 (2005) 245-252
30. Wiegand S., Dunne A.A., Muller H.H., Mandic R., Barth P., Davis R.K., and Werner J.A. Metaanalysis of the significance of matrix metalloproteinases for lymph node disease in patients with head and neck squamous cell carcinoma. Cancer 104 (2005) 94-100
31. Guenzi E., Topolt K., Lubeseder-Martellato C., Jorg A., Naschberger E., Benelli R., Albini A., and Sturzl M. The guanylate binding protein-1 GTPase controls the invasive and angiogenic capability of endothelial cells through inhibition of MMP-1 expression. EMBO J. 22 (2003) 3772-3782
32. Jadhav U., Chigurupati S., Lakka S.S., and Mohanam S. Inhibition of matrix metalloproteinase-9 reduces in vitro invasion and angiogenesis in human microvascular endothelial cells. Int. J. Oncol. 25 (2004) 1407-1414
33. Jeong J.W., Cha H.J., Yu D.Y., Seiki M., and Kim K.W. Induction of membrane-type matrix metalloproteinase-1 stimulates angiogenic activities of bovine aortic endothelial cells. Angiogenesis 3 (1999) 167-174
34. Plaisier M., Kapiteijn K., Koolwijk P., Fijten C., Hanemaaijer R., Grimbergen J.M., Mulder-Stapel A., Quax P.H., Helmerhorst F.M., and van Hinsbergh V.W. Involvement of membrane-type matrix metalloproteinases (MT-MMPs) in capillary tube formation by human endometrial microvascular endothelial cells: role of MT3-MMP. J. Clin. Endocrinol. Metab. 89 (2004) 5828-5836
35. Kim S.Y., Jung S.H., and Kim H.S. Curcumin is a potent broad spectrum inhibitor of matrix metalloproteinase gene expression in human astroglioma cells. Biochem. Biophys. Res. Commun. 337 (2005) 510-516
36. Shao Z.M., Shen Z.Z., Liu C.H., Sartippour M.R., Go V.L., Heber D., and Nguyen M. Curcumin exerts multiple suppressive effects on human breast carcinoma cells. Int. J. Cancer. 98 (2002) 234-240
37. Banerji A., Chakrabarti J., Mitra A., and Chatterjee A. Effect of curcumin on gelatinase A (MMP-2) activity in B16F10 melanoma cells. Cancer Lett. 211 (2004) 235-242